News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Enterprise Associates 16, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
|
|
| 12/27/2021 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 37,570 shares
@ $1.321, valued at
$49.6k
Sold 288,768 shares
@ $1.0018, valued at
$289.3k
Sold 170,932 shares
@ $0.9101, valued at
$155.6k
|
|
| 10/19/2021 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 1,851,852 shares
@ $0
Bought 1,851,852 options to buy
@ $1.37, valued at
$2.5M
|
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 4,398,602 shares
@ $0.622, valued at
$2.7M
Bought 5,239,254 warrants
@ $0.7464, valued at
$3.9M
Bought 258,707 options to buy
@ $6.22, valued at
$1.6M
|
|
| 09/22/2020 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Converted 1,958,333 shares
@ $0
Converted 332,964 shares
@ $0
Bought 769,230 shares
@ $13, valued at
$10M
Converted 1,958,333 convertible preferred
@ $0
Converted 332,964 convertible preferred
@ $0 |
|
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 564 shares
@ $2.66, valued at
$1.5k
Exercised (in-or-at-the-money) 1,500,000 options to buy
@ $0.001, valued at
$1.5k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2019 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Converted 3,736,243 shares
@ $0
Bought 450,000 shares
@ $15, valued at
$6.8M
Converted 29,889,945 preferred shares
@ $0 |
|
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2019 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 1,938,562 shares
@ $0
Bought 1,000,000 shares
@ $10, valued at
$10M
Bought 1,500,000 shares
@ $10, valued at
$15M
Converted 17,099,315 preferred shares
@ $0 |
|
| 05/09/2019 |
4
| Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 1,136,704 shares
@ $1.08, valued at
$1.2M
Bought 3,703,704 warrants
@ $1.08, valued at
$4M
Bought 256,700 options to buy
@ $10.8, valued at
$2.8M
|
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|